VWF and shear-dependent p125FAK phosphorylation . MoAbs 6D1 (anti-GPIb) and 328 (anti-vWF A1 domain), completely abolished SIPA and p125FAK phosphorylation mediated by 2B-rvWF. In contrast, neither RGDS peptide nor MoAb 7E3, both known to block IIb 3 engagement, had any effect on SIPA and pp125FAK. The size of aggregates formed at high shear rate in the presence of 2B-rvWF was decreased by genistein, demonstrating the biological relevance of pp125FAK. These findings provide a unique mechanism whereby the enhanced interaction of 2B-rvWF with GPIb, without engagement of IIb 3, is sufficient to induce SIPA but does not lead to stable thrombus formation.
INTRODUCTION
Platelets play a critical role in the arrest of bleeding by adhering to vascular matrix proteins and to other activated platelets at sites of vessel wall injury. High shear rates generate forces between platelets and the damaged vessel wall, that induce specific ligand-receptor interactions required for platelet adhesion, activation and aggregation. A key adhesive protein initiating platelet-vessel wall interactions is the large multimeric protein, von Willebrand factor (vWF) . When immobilized at the site of injury, vWF exhibits its A1 domain, allowing the capture of platelets from rapidly flowing blood by an interaction with the glycoprotein (GP) Ib/V/IX complex. This binding generates signals leading to IIb 3 integrin activation which becomes competent to interact with vWF and to promote irreversible platelet adhesion [1] [2] [3] [4] . In vitro, the change in vWF can be mimicked by the binding of vWF to its modulators ristocetin or botrocetin 5, 6 . High shear rates are important not only in the initial contact of platelets with the vessel wall, but also in the process of platelet aggregation, where fluid-phase vWF is required to stabilize platelet-platelet interactions and thrombus growth 7 . The mechanism of shear-induced platelet aggregation (SIPA) differs from conventional platelet aggregation observed under stirring conditions, essentially because the latter involves the binding of fibrinogen to activated IIb 3 receptor 8 . Based on studies performed with viscometers in which uniform shear fields can be applied in the absence of exogenous modulators, the following working model has been proposed : 1) in high shear rate conditions, fluid-phase vWF becomes able to bind to GPIb; 2) IIb 3 becomes activated through intracellular signals generated by vWF-GPIb complex formation; 3) activated IIb 3 binds to the RGD sequence of vWF, thereby stabilizing platelet aggregation 9, 10 . Using antibodies against vWF, GPIb or IIb 3 as well as platelet-rich plasma from patients with von Willebrand disease, Glanzmann's thrombasthenia or Bernard-Soulier syndrome, an interaction of vWF with both its receptors has been confirmed in SIPA 10,11 12 .
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From Under high shear conditions, evidence has been provided that the vWF-GPIb interaction leads to activation of IIb 3 through the initiation of signaling pathways that involve transmembrane calcium influx or protein kinase C activation 13, 14 . In addition, protein tyrosine phosphorylations have been demonstrated resulting from the interaction between vWF and both GPIb and IIb 3 integrin 15, 16 . Other studies have described tyrosine phosphorylated proteins of platelets in the presence of vWF and non-physiological agonists such as ristocetin, botrocetin or alboaggregin which induce binding to GPIb [17] [18] [19] [20] [21] . More recently, signaling events resulting from the interaction between GPIb and vWF were distinguished from those initiated by IIb 3 engagement with vWF, the latter requiring PI 3-kinase activation 22 , 23 . Thus, it remains to be determined whether under high shear conditions, engagement of IIb 3 is an obligatory consequence of the signaling pathway triggered by the vWFGPIb interaction.
We have previously established that recombinant vWF reproducing type 2B von Willebrand disease mutations (2B-rvWF), characterized by an increased affinity for GPIb, induced complete SIPA at high shear rates by a mechanism that was primarily mediated by GPIb 24 . In the present study, we addressed the issue of a signal transduction pathway that sustains the platelet response induced by the vWF-GPIb axis. Our results showed that SIPA induced by 2B-rvWF was associated with tyrosine phosphorylations of platelet proteins, and in particular of p125FAK. A major finding was that in the presence of 2B-rvWF, activation of p125FAK was correlated with a high level of platelet aggregation, which could not be abrogated by RGDS, suggesting that activation of p125FAK occurred independently of IIb 3 activation.
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MATERIALS AND METHODS

Antibodies and reagents
Synthetic peptide Arg-Gly -Asp-Ser (RGDS), leupeptin, aprotinin, wortmannin, genistein, sodium orthovanadate (Na 3 VO 4 ), -glycerophosphate, sodium fluoride (NaF), apyrase, adenosine 5' phosphate (ADP), and adenosine 2', 5'-diphosphate (A2P5P) were purchased from Sigma (St Louis, MO .
Plasmid constructs, cell culture and transfection
Plasmids with full-length complementary DNA (cDNA) coding for WT-rvWF (WTpNUT) or mutated 2B-rvWF with substitution of methionine in position 553 for valine
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From (V553M) were constructed as previously described 29, 30 . The mutant was confirmed by restriction enzyme digests.
For stable transfection of WT-or 2B-rvWF V553M, a baby hamster kidney (BHK) cell line overexpressing furin was established using the lipofectamine method as previously described 29 . The culture supernatant of these cell lines was harvested every 3 to 4 days, and the amount of rvWF was estimated by ELISA using a pool of 12 MoAbs to vWF 24 . The concentration of rvWF was estimated between 2 and 8 µg/mL in the cell expression medium. In some experiments we used 2B-rvWF M540MM (duplication of methionine at position 540) expressed by COS cells 24 .
Purification of WT-and 2B-rvWFs
WT-rvWF and 2B-rvWF were purified by immunoaffinity chromatography on CNBractivated Sepharose 4B (Amersham) coupled to a MoAb 453, directed against the Cterminal part of the vWF subunit and produced in our laboratory. The MoAb 453
Sepharose column was equilibrated with 50 mM Tris/100 mM NaCl (TBS), pH 7.4.
Expression medium was applied to the column and bound rvWF was eluted in 1 mL fractions using 50 mM triethylamine (TEA) pH 11-12, which was immediately neutralized with 2 M glycine, pH 3. RvWF-containing fractions were stored at -80°C.
Characterization of WT-and 2B-rvWFs
The multimeric composition of rvWFs, analysed by 0.1% sodium dodecyl sulfate (SDS) and 1% agarose gel electrophoresis, was similar in 2B-rvWF and WT-rvWF 31 .
Subunit analysis was performed by electrophoresis on 0.1% SDS-5% polyacrylamide gel under reducing conditions followed by immuno-transfer to a nitrocellulose membrane (Bio-rad) 32 and showed that both WT-and 2B-rvWF were secreted as full-length mature vWF. Binding of mutated and WT-rvWFs to formalin-fixed platelets was performed using 125 I-MoAb 505 (anti-vWF) as a tracer in the presence of ristocetin or botrocetin as described 24 .
In the presence of 1 mg/mL of ristocetin, WTrvWF as well as 2B-rvWF exhibited binding to GPIb reaching 69.2% and 80.1 % For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From respectively. At low concentration of ristocetin, 2B-rvWF showed increased binding to GPIb (65.4%), whereas WT-rvWF was unable to bind to platelets (5.9%).
Preparation of washed platelets
Blood was obtained from healthy individuals who had not ingested any medication for 2 weeks before donation with acid-citrate-dextrose (ACD) 15% as anticoagulant.
Washed platelets were prepared as previously described 24 . Briefly, platelets were isolated from platelet-rich-plasma by centrifugation at 220 g for 15 minutes at 37°C and washed twice with Hepes buffer pH 6.7 (10 mM Hepes; N- [2- hydroxyethyl]piperazine-N'-[ethanesulfonic acid], 136 mM NaCl, 2.7 mM KCl, 2 mM MgCl 2 ) containing 0.35% BSA in the presence of apyrase (2 U/mL) and ACD (2.5%).
Platelets were resuspended in Hepes buffer pH 7.5 containing 0.025% BSA, and the concentration was counted with an electronic particle counter (Model 1, Coulter Electronics, Margency, France).
Shear induced platelet aggregation (SIPA)
The rotating device is a Couette type viscosimeter used as previously described with minor modifications 12 . Washed platelets (2.8 x 10 8 /mL) were exposed for 4.5 minutes at 37°C to a continuous shear rate of 200 or 4,000 s -1 in the presence of rvWF and 1 mM CaCl 2 . Recombinant proteins were adjusted to a final concentration of 0.7 µg/mL (2B-rvWF) or 4 µg/mL (WT-rvWF) in cell expression medium. In some experiments, purified rvWF was used at final concentrations varying from 0.7 to 5 µg/mL for 2B-rvWF or 10 to 34 µg/mL for WT-rvWF. or 7E3 (20 µg/mL), RGDS (1 mM) or EDTA (2 mM). Alternatively, platelets were preincubated for 30 minutes at room temperature with genistein (100-1000 µM), or for 15 min at 37°C with wortmannin (100 nM) before being submitted to shear. Means ± SEM were calculated from 3 experiments. In some experiments, after exposure to shear an aliquot of the fixed platelet suspension was deposited in 96-multiwell plastic plates (Nunc, Roskilde, Denmark). Following sedimentation in the wells, aggregates were observed at a 10-fold magnification using an Axiovert 135 inverted microscope (Zeiss, Germany). Images were observed with a charged-coupled-device (CCD) camera (Sony, Tokyo,Japan) and vizualized using a standard display VGA monitor (Microvision Instruments, Evry, France) .
ADP and thrombin-induced platelet aggregation
Washed platelets (2.8 x 10 8 /mL) were supplemented with 1 mM CaCl 2 and preincubated with either purified WT-rvWF or 2B-rvWF (8 µg/mL) for 2 min at 37°C. Platelet aggregation was initiated by adding thrombin (0.01-0.1 U/mL), monitored under constant stirring in a lumi-aggregometer (Chrono-Log, Coultronics, France) for 2 min at 37°C, and was quantitated by measuring maximal intensity. For positive control of specific inhibitors, platelets were preincubated with each blocker as described above and platelet aggregation was initiated by adding thrombin (0.5 U/mL) alone or ADP (5 µM) with fibrinogen (0.7 mg/mL) (Merck Eurolab).
Preparation of cell lysates and western blot analysis
Following exposure to shear, platelet suspensions (160 µl) were solubilized in the cylinder in the absence of shear with 40 µL of denaturing buffer (10% SDS, 100 mM NaCl, 50 SDS, 10 µg/mL bromophenol blue) containing 10 mM dithiothreitol. Samples were heated at 100°C for 15 minutes and proteins were separated by SDS-polyacrylamide gel electrophoresis (SDS-PAGE), in a 8% polyacrylamide gel. Separated proteins were transferred electrophoretically to a nitrocellulose membrane. The membrane was incubated overnight at 4°C with a blocking buffer containing 5% skimmed low-fat milk, 2% Tween 20, 100 mM NaCl and 20 mM Tris pH7.4 (T-TBS). Membranes were then incubated for 2 hours at room temperature with the combination of two antiphosphotyrosine antibodies 4G10 and PY20 (1:10,000), washed extensively with T-TBS and incubated with horseradish peroxidase-conjugated secondary antibody (1:10,000) for one hour at room temperature. Immunoreactive bands were detected by chemiluminescence system (Amersham, Little Chalfont, Bucks, UK). In some experiments, the membranes were stripped, bound antibody was removed by incubation in buffer containing 2% SDS, 62.5 mM Tris, pH 6.8, and 100 mM 2-mercaptoethanol for 45 minutes at 60°C. After extensive washing, the membrane was reprobed with anti-phosphoFAK antibody (1:10,000) as described above.
Quantitation of p125FAK phosphorylation was performed by scanning autoradiographs using Hyrys 2 densitometer (Sebia, Issy les Moulineaux, France) and expressed as arbitrary units. Interestingly, similar bands of tyrosine phosphorylated proteins were obtained using purified 2B-rvWF (5-10 µg/mL). Identical results were also obtained using another 2B-rvWF mutant (M540MM), which was previously described to induce high SIPA 24 (data not shown). As a control of tyrosine-phosphorylated proteins following agonistinduced activation, we prepared platelet samples stimulated with thrombin (0.5 U/mL). In particular, compared to resting (non-stimulated) platelets, we observed the appearance of a 97-kDa protein, which was previously reported to be associated specifically with the presence of large aggregates following activation with strong agonists 33 . This 97-kDa protein was not seen in the samples exposed to high shear rate in the presence of 2B-rvWF, despite the almost complete SIPA (>90% DSP) ( Figure 2 ).
Statistical analysis
2B-rvWF dependent p125FAK phosphorylation is specific of high shear rates
In the presence of 2B-rvWF, at 4,000 sec upper part). In contrast, a faint phosphorylation of p125FAK was observed in samples containing 2B-rvWF in the absence of shear rates, and no increase was seen in samples devoid of 2B-rvWF, whether in the presence or absence of shear.
As a positive control, we showed an increased phosphotyrosine intensity in the sample stimulated with 0.5 U/mL thrombin, as previously reported for p125FAK phosphorylation in thrombin-stimulated platelets 34 . We probed the lysates for their p125FAK protein content using antibody against non-phosphorylated form, and found that differences in phosphorylation were not related to variations in protein content We next attempted to understand the relationship, if any, between the extent of SIPA and that of pp125FAK, and to determine if 2B-rvWF was able to modify p125FAK
For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From phosphorylation. In the presence of 2B-rvWF, at 4,000 sec -1 , SIPA reached 97.1±0.4% (n=14), a value significantly higher than that (32.6±1.9%) in the absence of shear (p<0.0001). These results were compared with variations of pp125FAK intensities, quantitated in the corresponding samples. We found that at 0 sec -1 , OD of pp125FAK corresponded to 0.9±0.1 arbitrary units (AU), while it increased to 2.9±0.2 AU at high shear rate (p<0.0001). Thus, in order to establish whether the increased p125FAK phosphorylation at high shear was specific of 2B-rvWF, we compared the ability of increasing concentrations of purified 2B-rvWF and WT-rvWF, to induce an increase in p125FAK phosphorylation (Figure 4 ).
Between 0.7 µg/mL and 5 µg/mL 2B-rvWF, SIPA increased from 70 to 98%; in this range of 2B-rvWF, the extent of p125FAK phosphorylation increased almost linearly from 0.9 to 3.8 AU, and did not reach a plateau (Figure 4, panel A) . In the presence of WT-rvWF, SIPA increased in a dose-dependent manner between 0 and 34 µg/mL, For personal use only. on November 16, 2017 . by guest www.bloodjournal.org From up to DSP of 67.9%. It should be noted that despite the 7-fold higher concentration of WT-than of 2B-rvWF, SIPA remained under the plateau observed at 2B-rvWF concentrations between 0.7 µg/mL and 5 µg/mL. The OD of pp125FAK was 0.9±0.1 AU, and did not increase as a function of WT-rvWF concentration (Figure 4, panel B) .
Thus, in this range of WT-rvWF concentrations, SIPA increased whereas pp125FAK did not.
Effect of GPIb-vWF blockers on tyrosine phosphorylations induced by 2B-rvWF
We have previously established that SIPA in the presence of 2B-rvWF predominantly involves the interaction between GPIb and 2B-rvWF Interestingly, p125FAK-tyrosine phosphorylation was also strongly inhibited by MoAbs 6D1 and 328 ( Figure 5 panel B) . These results suggested that tyrosine phosphorylations and p125FAK phosphorylation were primarily dependent on the interaction between GPIb and 2B-rvWF at high shear rates.
For
Effect of tyrosine kinase inhibitors and ADP receptor blockers
In order to further understand the relationship between SIPA and tyrosine phosphorylations, we investigated the effect of the tyrosine kinase inhibitor genistein on SIPA in the presence of 2B-rvWF. Genistein inhibited in a dose-dependent manner protein tyrosine phosphorylations (Figure 6 panel A) and tyrosine phosphorylation of p125FAK (Figure 6 panel B) .
Preincubation of platelets with genistein did not result in a significant variation of the % DSP from 98% in the absence of genistein, to 88 % in the presence of 1000 µM genistein (Figure 6 panel B) . However, microscopic observation of platelet aggregates showed that the size of aggregates was reduced by genistein in a dose- (Figure 6 panel C) . It is interesting to note that 2B-rvWF dependent aggregate formation at high shear rate was reversible, when the exposure to shear was discontinued. Indeed, the fixation step by PFA was required to prevent loss of aggregates (data not shown). 
These results suggest that in conditions where genistein blocked efficiently activation of tyrosine kinases involved in p125FAK phosphorylation, it was able to decrease the size of aggregates resulting from 2B-rvWF-dependent SIPA at high shear rate.
In separate experiments, we determined the effect of inhibitors of ADP on SIPA and p125FAK phosphorylation in samples exposed to high shear and 2B-rvWF. We found that apyrase or A2P5P was without effect on SIPA and p125FAK phosphorylation (data not shown). These results suggest that 2B-rvWF-dependent SIPA and tyrosine phosphorylations were unlikely to involve ADP secretion from dense granules, but as it was obtained using washed platelets, may differ from studies in whole blood or PRP showing a role for ADP receptors in SIPA 35 .
Effect of IIb 3-vWF blockers on SIPA and tyrosine phosphorylations induced by 2B-rvWF at high shear rates
We and others have previously established that SIPA at high shear rates involves partially an interaction between plasma-derived vWF and IIb 3 [12] [13] [14] . In the present study, using 2B-rvWF at 4,000 sec (Figure 7 Panel A). However, we verified that the latter blockers were still able to block thrombin-induced tyrosine phosphorylations, as reported 33, 36 .
In separate experiments, kistrin, an RGD-containing cystein-rich peptide and a potent antagonist of IIb 3 28 , was studied for its effect on 2B-rvWF-dependent SIPA and on tyrosine phosphorylation. In agreement with the absence of effect by RGDS, no inhibition was found on % DSP and tyrosine phosphorylation (not shown). Microscopic observation of platelet aggregates which were formed in the presence of 2B-rvWF at high shear rate did not indicate any difference in the size of aggregates in the presence of 50 nM kistrin (Figure 7 panel B) . Accordingly, when we measured PAC-1 binding to platelets exposed to high shear in the presence of 2B-rvWF, we found less than 3% platelets bound to PAC-1, while 35% of platelets were positive for PAC-1 after thrombinstimulation (data not shown). (bottom), were exposed to shear and fixed with PFA. An aliquot was deposited in microtiter plates for microscopic observation of aggregates, as described in the legend of Figure 6C .
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From Finally, platelets stimulated with ADP (1 µM) were able to aggregate in the presence of purified 2B-rvWF; this aggregation was inhibited by RGDS or MoAb 7E3, suggesting that 2B-rvWF exhibited a functional binding site towards activated IIb 3.
Indeed, this low ADP concentration was not sufficient to induce a release from alphagranules, ruling out that aggregation involved released fibrinogen or vWF (data not shown). Altogether, these results suggest that IIb 3 engagement was not required in 2B-rvWF induced tyrosine phosphorylations and p125FAK phosphorylation at high shear rate.
2B-rvWF dependent tyrosine phosphorylations are independent of PI 3-kinase
Previous studies have demonstrated the requirement of PI 3-kinase activation and calcium flux in mechanisms resulting from the interaction between GPIb and vWF and leading to IIb 3 activation 22 . In order to elucidate a potential role of PI 3-kinase, we have tested the effect of wortmannin, a potent inhibitor of PI 3-kinase. 
DISCUSSION
The interaction between GPIb and vWF plays a critical role in platelet adhesion and aggregation under high shear rates. Signals resulting from this interaction are required to maintain stable platelet interaction with vWF 11, 14, 22, 37 . In the present study we describe tyrosine phosphorylations in a SIPA model allowing to show predominantly the contribution of mutated 2B-rvWF binding to GPIb. Two main findings are described in this study: i) the interaction between GPIb and 2B-rvWF at high shear rate induced p125FAK phosphorylation and ii) the involvement of IIb 3 integrin was not required for 2B-rvWF dependent SIPA and p125FAK phosphorylation. domain, have shed a new light on the mechanism of these gain-of-function mutations related to bleeding disorders. These mutations are located on an amino-terminus extension, which in the wild-type A1 normally covers an important contact site of GPIb, and should be dislodged for maximal binding of GPIb. Mutations would favor the bound conformation at this GPIb contact sites, and presumably shear could increase the exposure of the second binding site of GPIb 39, 40 . We show that 2B-rvWF induced SIPA in a shear-dependent manner from 200 to 4,000 sec -1 , an effect that was abrogated in the presence of MoAbs blocking vWF-GPIb binding. We have previously established that 2B-rvWF-dependent SIPA is closely correlated with 2B-rvWF ability to bind GPIb at low ristocetin concentrations 24 . In the present study, we extend our previous data concerning the important role of GPIb in promoting SIPA by demonstrating a dose-dependent response of SIPA with increasing concentrations of purified 2B-rvWF.
The bleeding disorder of type 2B vWD is paradoxical, since individuals with increased interaction between vWF and GPIb could be expected to display increased thrombus formation. Although little is known about the mechanism of thrombus formation in type 2B vWD, an heterogenous defect in thrombus growth has been recently demonstrated in perfusion studies on collagen. Indeed, 2 out of 4 patients' blood lead to an impaired thrombus generation measured by epifluorescence microscopy, whereas confocal microscopy, which required fixation of the blood sample, allowed to identify in all patients' blood an homogenous defect in thrombus spatial growth 41 . It is our hypothesis that this requirement for fixation is in favor of reversible aggregate formation in type 2B vWD. Indeed, we have observed the formation of unstable aggregates induced by type 2B at high shear rate, since in the absence of PFA, aggregates were no longer seen over time after cessation of the shear. Interestingly, we could extend this observation to Glanzmann's thrombasthenia type 1 platelets. Indeed, aggregates were formed in the presence of 2B-rvWF at 4000 sec -1 , and these aggregates were unstable in the absence of fixation by PFA (data not shown).
A key question raised by the present study on the pathophysiological mechanism is the possible lack of involvement of IIb 3 activation in SIPA. We establish that under high shear rates, 2B-rvWF-dependent SIPA was unaffected by RGDS peptide or MoAb 7E3, which block IIb 3 integrin function. In favor of our hypothesis that binding of 2B-rvWF to GPIb does not lead to IIb 3 activation, we found that PAC-1 binding to platelets exposed to 2B-rvWF at high shear rate did not exceed 3%. To rule out a defect of the mutant, we have verified that 2B-rvWF exposes normally its functional binding site to IIb 3, since it was able to promote platelet aggregation at Therefore, SIPA induced signaling pathways which resulted in different activated proteins from the three phosphorylated proteins of 97, 95 and 84 kDa observed using strong agonists, which were dependent on stirring and aggregation 33, 36 . Indeed, these authors reported that these phosphorylated proteins were not seen in platelets in the presence of vWF and ristocetin 33 . Therefore, we propose a model where SIPA induced by 2B-rvWF in high shear rate conditions results in protein tyrosine phosphorylation profiles distinct from those previously found specifically in the presence of large aggregates, and presumably linked to engagement of activated IIb 3 36 . Interestingly, when SIPA was obtained at high shear rate in the presence of 2B-rvWF, we observed tyrosine phosphorylations which were dependent on GPIb, since they were abolished in the presence of GPIb blockers. Other groups have reported an increase in protein tyrosine phosphorylations at position 130, 100, 85, 15, 16 . In the absence of shear, vWF-dependent platelet aggregation in the presence of non-physiological agonists (ristocetin or botrocetin) was also associated with increased protein tyrosine phosphorylations at position 64 kDa or 72 kDa 19 , 20, 44 .
More precisely, p125FAK, p72Syk, PLC 2 and SHIP were phosphorylated in the presence of ristocetin 19 . However, phosphorylation of the latter three proteins was also strongly inhibited by MoAb IV.3 which inhibits Fc RII activation 19 . Indeed, GPIb cross-linking with the Fc RII receptor could contribute to increase tyrosine phosphorylations, since a physical proximity of both receptors has been reported 45 and cross-linking of Fc RII with secondary antibodies triggers the tyrosine phosphorylation of multiple cellular proteins 46, 47 . We have studied the effect of MoAb IV.3 on SIPA induced by 2B-rvWF using blood samples from six different donors, but we were unable to find an inhibition of SIPA (data not shown). This result is in agreement with a previous finding that p125FAK phosphorylation was unaffected by MoAb IV. We demonstrated that at 4,000 sec -1 , increased SIPA and p125FAK phosphorylation were strongly dependent on type 2B-rvWF interaction with GPIb, since MoAbs 6D1
and 328 completely blocked both events. Furthermore, whereas thrombin-induced p125FAK phosphorylation was completely inhibited by 1 mM RGDS and 7E3 in an aggregometer, these two inhibitors were unable to block p125FAK phosphorylations at 4,000 sec -1 in the presence of type 2B-rvWF. Our results suggest that IIb 3 engagement was not required for both SIPA and p125FAK phosphorylation in the presence of 2B-rvWF under high shear rates. Our results are in agreement with previous data showing that RGDS did not inhibit ristocetin-induced platelet aggregation 50 . However, they are at variance with those showing that SIPAassociated tyrosine phosphorylations were inhibited by RGDS, although there was no
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From evidence of p125FAK phosphorylation 15, 16 . It has been shown that p125FAK phosphorylation is dependent on post-occupancy events in thrombin-stimulated platelets 51 , or in platelets co-stimulated by epinephrine and by an anti-3 LIBS antibody 34 . However, there is also evidence that phosphorylation may occur independently of IIb 3 engagement, such as the p125FAK tyrosine phosphorylation in collagen-stimulated platelets involving GPVI 52 . Furthermore, it has been shown that a peptide fused to the cytoplasmic tail of IIb which allows conditional clustering of IIb 3, could also promote FAK phosphorylation without fibrinogen binding to IIb 3 53 . Platelets from patients with Glanzmann's thrombasthenia showed similar low density lipoprotein-induced FAK phosphorylation as control platelets 54 . Integrinindependent phosphorylation of p125FAK has also been reported in platelets activated using immobilized human IgG, an event that depends on Fc RII 55 .
An intriguing finding was that p125FAK phosphorylation was detected in 2B-rvWFdependent SIPA but not in WT-rvWF dependent SIPA. This finding was observed whether using V553M or M540MM 2B-rvWF, thus was not related to a particular mutation responsible for the type 2B vWD phenotype. Several hypothesis could explain this discrepancy. Firstly, p125FAK phosphorylation may correspond to a mechanism similar to a post-aggregation event. Indeed, p125FAK phosphorylation may require the very high level of SIPA obtained at high shear rates and in the presence of 2B-rvWF, but not that obtained in the presence of WT-rvWF, which remained always lower. In that manner, the mechanism of p125FAK phosphorylation would be close to the relationship previously established between tyrosine phosphorylations and the intensity of platelet aggregation 36 . Secondly, an activation of p125FAK kinase activity may be triggered by high shear rates and in the presence of 2B-rvWF, whereas a phosphatase activity may be down-regulated by 2B-rvWF and normally activated by WT-rvWF. A third hypothesis is that p125FAK phosphorylation involves different mechanisms in either WT-rvWF or 2B-rvWF dependent SIPA. We found that RGDS or 7E3 was without effect on 2B-rvWF dependent p125FAK phosphorylation as well as SIPA. In contrast, we have previously reported that plasma derived vWF-dependent SIPA was reduced two-fold by inhibitors of IIb 3-vWF interaction, MoAb 9 or 10E5 12 . Finally, in keeping with situations where SIPA reached 60-70% DSP without inducing p125 FAK phosphorylation, we may also suggest that the p125 FAK phosphorylation requires both a threshold DSP (e.g.>80%) and an additional signaling mechanism. In favor of this mechanism, we found that at shear rate of 500 and 1000 sec-1, 2B-rvWF associated p125FAK phosphorylation was also significantly increased (data not shown). By comparing 2B-rvWF-dependent and thrombin-dependent signals, we suggest that increasing the affinity of vWF for GPIb could substitute for mechanisms of signal transduction depending on IIb 3 integrin engagement. This hypothesis is also supported by the finding that 2B-rvWF dependent signal transduction did not involve PI-3 kinase activation, wheras it has been shown that platelet adhesion to vWF under high shear rate leads to IIb 3 integrin activation through PI-3 kinase activation 22, 56 .
We found that the interaction between 2B-rvWF and GPIb at high shear was able to induce FAK phosphorylation without requiring IIb 3 integrin engagement. This suggests that 2B-rvWF dependent SIPA did not required tyrosine phosphorylations to maintain stable aggregation but induced signal transduction independently of IIb 3 integrin engagement. Similar results have been previously described using ristocetin as agonist 19 .
Altogether, our findings indicate that 2B-rvWF is able to induce p125FAK phosphorylation without affecting the 2B-rvWF/ IIb 3 interaction. This effect involves different elements, the increased affinity of 2B-rvWF for GPIb, the high level of aggregate formation, the clustering of platelet GPIb, as well as pp125FAK as shown by the effect of genistein on the size of aggregates. This study provides additional evidence for the paradoxical bleeding disorder and unstability of thrombi in type 2B vWD patients, and are in favor of a unique mechanism whereby circulating aggregates are independent of 2B-rvWF interaction with IIb 3 integrin, and thus, do not lead to thrombus formation. 
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